神經調控設備市場規模、佔有率和成長分析：按設備類型、應用、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球神經調節設備市場價值為 110 億美元，預計到 2025 年將成長至 115.4 億美元，到 2033 年將成長至 169.2 億美元，在預測期（2026-2033 年）內複合年成長率為 4.9%。

全球神經調控設備市場正經歷顯著成長，其主要驅動力是慢性疾病的日益普遍以及傳統藥物療法的限制。神經刺激技術的進步得益於人類神經系統功能特性以及電刺激治療各種疾病有效性的廣泛研究。這促成了新技術和新設備的開發，例如用於緩解疼痛的脊髓刺激和用於癲癇治療的迷走神經刺激。隨著神經刺激領域的不斷創新，針對特定疾病的專用設備也開始出現。然而，神經調控手術和設備的高昂成本以及熟練專家的短缺等挑戰可能會阻礙市場成長。

全球神經調控設備市場的成長要素

全球神經調控設備市場正因多種因素而蓬勃發展。其中一個主要促進因素是各種健康問題的日益普遍，這凸顯了此類設備在緩解包括慢性疼痛、偏頭痛和腦損傷在內的多種疾病方面的有效性。此外，神經調控設備在精神疾病、消化器官系統疾病和睡眠障礙的治療中也扮演著越來越重要的角色。這種在多個醫療領域的廣泛應用正在推動其普及和接受度，最終促進神經調控設備市場的成長，因為越來越多的患者正在尋求創新的解決方案來滿足其多樣化的醫療需求。

全球神經控制設備市場的限制因素

全球神經調控設備市場面臨許多挑戰，阻礙其發展。其中一個主要障礙是需要大量資本投入，這對於試圖在該行業站穩腳跟的新參與企業尤其構成重大阻礙。此外，這些設備的高昂製造成本也為新興企業帶來了進一步的困難。雪上加霜的是，能夠有效操作神經調控設備的專業人員短缺，因為這些設備的使用需要先進的專業知識和訓練。這些因素共同構成了目前限制市場擴張潛力的阻礙因素。

全球神經調控設備市場趨勢

全球神經調控設備市場正經歷顯著成長，其主要驅動力是慢性疾病患者數量的不斷增加，例如背痛、憂鬱症、癲癇和睡眠呼吸中止症等。這些疾病往往對傳統藥物治療無效。醫療管理模式的轉變促使醫療機構將神經刺激技術作為替代治療方法，以期改善患者預後並提供創新解決方案。隨著神經調控技術在緩解這些慢性疾病症狀方面的有效性不斷得到醫學界的認可，預計在設備功能不斷提升和對個人化治療方案日益重視的推動下，市場將繼續擴張。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球神經控制設備市場規模：依設備類型分類

• 經顱裝置
  • 經顱磁刺激
  • 脈衝經顱磁刺激
  • θ 脈衝刺激
  • 經顱直流電刺激
  • 陽極刺激
  • 陰極刺激
• 嵌入式裝置
  • 深部腦部刺激
  • 高頻刺激
  • 脈衝串刺激
  • 脊髓刺激療法
  • 傳統脊髓刺激
  • 刺激背根神經節

全球神經控制設備市場規模：按應用領域分類

• 慢性疼痛管理
  • 腰痛
  • 神經病變疼痛
• 心理健康
  • 憂鬱症
  • 焦慮症

全球神經控制設備市場規模：依最終用戶分類

• 醫院
  • 私立醫院
  • 公立醫院
• 神經科診所
  • 獨立診所
  • 聯網診所

全球神經控制設備市場規模：按分銷管道分類

• 直銷
• 銷售代理

全球神經控制設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Boston Scientific
• Abbott Laboratories
• Nevro Corporation
• Stimwave Technologies
• Helius Medical Technologies
• Nuvectra Corporation
• Soterix Medical
• Brainstorm Cell Therapeutics
• Bioness
• CHARITE-Universitatsmedizin Berlin
• Great Lakes NeuroTechnologies
• Cerevel Therapeutics
• Cerenovus
• Refresh Neuro
• IMThera Medical
• EBR Systems
• Synapse Biomedical
• Analogue Devices
• NeuroPace

結論與建議

Global Neuromodulation Devices Market size was valued at USD 11.0 Billion in 2024 and is poised to grow from USD 11.54 Billion in 2025 to USD 16.92 Billion by 2033, growing at a CAGR of 4.9% during the forecast period (2026-2033).

The global neuromodulation devices market is experiencing significant growth driven by the increasing prevalence of chronic conditions and the limitations of traditional pharmaceutical therapies. Advances in neurostimulation techniques are supported by extensive research on the functional properties of human nerves and the effectiveness of electrical stimulation in treating various ailments. This has led to the development of novel methods and devices, such as spinal cord stimulation for pain relief and vagus nerve stimulation for epilepsy management. The market is seeing the emergence of tailored devices aimed at specific conditions, reflecting ongoing innovation in neurostimulation. However, challenges such as the high costs associated with neuromodulation procedures and equipment, along with a shortage of skilled professionals, may impede market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuromodulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuromodulation Devices Market Segments Analysis

Global Neuromodulation Devices Market is segmented by Device Type, Application Area, End User, Distribution Channel and region. Based on Device Type, the market is segmented into Transcranial Devices and Implantable Devices. Based on Application Area, the market is segmented into Chronic Pain Management and Mental Health. Based on End User, the market is segmented into Hospitals and Neurology Clinics. Based on Distribution Channel, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neuromodulation Devices Market

The global neuromodulation devices market is gaining momentum due to several compelling factors. A primary driver is the rising prevalence of various health conditions, which has highlighted the effectiveness of these devices in providing relief from a range of ailments, including chronic pain, migraines, and brain injuries. Furthermore, neuromodulation devices are increasingly recognized for their role in managing mental health disorders, digestive problems, and sleep disturbances. This broad applicability across multiple medical domains has led to heightened adoption and acceptance, ultimately fueling the growth of the neuromodulation devices market as more patients seek innovative solutions for their diverse healthcare needs.

Restraints in the Global Neuromodulation Devices Market

The global neuromodulation devices market faces several challenges that hinder its growth. A primary obstacle is the substantial capital investment required, which presents a significant barrier, particularly for new entrants seeking to establish themselves in the industry. Additionally, the high manufacturing costs associated with these devices create further difficulties for emerging players. Compounding these issues is the shortage of skilled professionals who can effectively operate neuromodulation devices, as their use demands a high level of expertise and training. Together, these factors contribute to the constraints currently affecting the market's potential for expansion.

Market Trends of the Global Neuromodulation Devices Market

The Global Neuromodulation Devices market is experiencing significant growth, fueled by an increasing patient population suffering from chronic conditions like back pain, depression, epilepsy, and sleep apnea, which often exhibit resistance to traditional pharmaceuticals. This evolution in healthcare management has led providers to prioritize neurostimulation techniques as alternative therapeutic options, enhancing patient outcomes and offering innovative solutions. As the medical community continues to recognize the efficacy of neuromodulation technologies in alleviating symptoms of these persistent disorders, the market is set to expand, marked by continuous advancements in device capabilities and an increasing focus on personalized treatment regimens.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Neuromodulation Devices Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Transcranial Devices
  • Transcranial Magnetic Stimulation
  • Pulse-TMS
  • Theta Burst Stimulation
  • Transcranial Direct Current Stimulation
  • Anodal Stimulation
  • Cathodal Stimulation
• Implantable Devices
  • Deep Brain Stimulation
  • High-Frequency Stimulation
  • Burst Stimulation
  • Spinal Cord Stimulation
  • Conventional SCS
  • Dorsal Root Ganglion Stimulation

Global Neuromodulation Devices Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Chronic Pain Management
  • Back Pain
  • Neuropathic Pain
• Mental Health
  • Depression
  • Anxiety Disorders

Global Neuromodulation Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
  • Private Hospitals
  • Public Hospitals
• Neurology Clinics
  • Independent Clinics
  • Networked Clinics

Global Neuromodulation Devices Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors

Global Neuromodulation Devices Market Size & CAGR (2026-2033)

• North America (Device Type, Application Area, End User, Distribution Channel)
  • US
  • Canada
• Europe (Device Type, Application Area, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Application Area, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Application Area, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Application Area, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helius Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvectra Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainstorm Cell Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioness
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CHARITE - Universitatsmedizin Berlin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Great Lakes NeuroTechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerevel Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerenovus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Refresh Neuro
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IMThera Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EBR Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analogue Devices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations